Alterity Therapeutics Limited | PRAN - Selling And Administration Expenses


Alterity Therapeutics Limited reported AUD2.29M in Selling and Administration Expenses for its fiscal semester ending in June of 2023.





Selling And Administration Expenses Change Date
Alterity Therapeutics Limited AUD 2.29M 649.1K Jun/2023
Arca Biopharma USD 5.16M 346K Mar/2025
aTyr Pharma USD 4.8M 130K Sep/2025
Brainstorm Cell Therapeutics USD 1.78M 319K Mar/2025
Capricor Therapeutics USD 5.88M 1.6M Mar/2025
Cara Therapeutics USD 4.64M 2.19M Mar/2025
CSL USD 727M 453M Jun/2025
Esperion Therapeutics USD 39.98M 4.21M Sep/2024
Immunic USD -0.24 0.03 Sep/2024
Insmed USD 186.38M 109.94M Sep/2025
Minerva Neurosciences USD 2.48M 58.79K Sep/2024
Sangamo BioSciences USD 9.64M 1.83M Jun/2024
TherapeuticsMD USD 1.23M 90K Jun/2024